title: Occlusion of modified Blalock-Taussig shunt after clopidogrel cessation.
abstract: It has been suggested previously that rebound hypercoagulability may be responsible for morbidity and mortality following clopidogrel cessation in adults with acute coronary syndrome. We report a case of acute occlusion of a modified Blalock-Taussig shunt in an infant after clopidogrel discontinuation.
authors.affiliation: Bristol Heart Institute, Histopathology Department, Bristol Royal Infirmary, Bristol, United Kingdom. avlonitis@hotmail.com
authors.forename: Vassilios Spiridon
authors.initials: VS
authors.lastname: Avlonitis
authors.forename: Silvia
authors.initials: S
authors.lastname: Planas
authors.forename: Alison M
authors.initials: AM
authors.lastname: Hayes
authors.forename: Andrew
authors.initials: A
authors.lastname: Parry
mesh_terms: D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D058366:Blalock-Taussig Procedure; D000077144:Clopidogrel; D017809:Fatal Outcome; D006083:Graft Occlusion, Vascular / Q000139:chemically induced* / Q000601:surgery / Q000628:therapy; D006323:Heart Arrest / Q000209:etiology; D006345:Heart Septal Defects, Ventricular / Q000601:surgery; D006801:Humans; D020925:Hypoxia-Ischemia, Brain / Q000209:etiology; D007231:Infant, Newborn; D008297:Male; D018633:Pulmonary Atresia / Q000601:surgery; D012086:Reoperation; D013226:Status Epilepticus / Q000209:etiology; D013375:Substance Withdrawal Syndrome / Q000209:etiology*; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D018785:Tricuspid Atresia / Q000601:surgery
chemical_list: D000925:Anticoagulants; D000077144:Clopidogrel; D013988:Ticlopidine; D001241:Aspirin